Insilico's new COVIDomic platform combines cutting-edge AI with Intel Xeon processors and could turn the pandemic tide.
Insilico have been rather busy lately; a couple...
New paper reviews how machine learning can support multimorbidity research to promote Longevity.
Longevity research has been able to leverage the power of machine learning...
Insilico and Harvard develop the first AI-powered microbiomic aging clock.
Scientists from Harvard Medical School and Insilico Medicine have used thousands of whole genome sequencing samples...
Comprehensive cellular senescence database will provide benchmark for the development of senolytic therapies.
Our cells are intrinsically programmed for senescence – a gradual aging and...
Consciousness in the cloud? Where science fact and fiction collide.
While the principle focus of Longevity is undoubtedly the extension of healthy human lifespan, there...
Experts, innovators, investors and the curious meet online in the biggest Longevity conference ever staged.
As we enter the fourth day of Longevity2020, we thought...
An in-depth preview of big-hitting AI speakers at the first ever online Longevity conference.
It's finally here - Longevity2020 week has arrived! Later today, we...
Dr Richard Siow talks COVID-19, its implications for Longevity, and how AI can play a role.
Scientists across the world are scrambling in response to...
We speak with a key contributor to the Longevity2020 online conference about biological aging.
UK start-up AgeCurve is focused on the measurement of aging and...
Virtuleap currently fundraising to build headcount and capitalise on cognitive illness detection algorithms.
Ever since the US Federal Trade Commission fined Lumosity $2 million for...
Researchers in Hong Kong have developed a tool which could hold another key to promoting Longevity.
Researchers in Hong Kong have developed a tool that...
University of Oslo researchers develop AI biomarker for tracking neurological treatment over time.
Finding timely therapies for age begins with finding a way to measure...
Researchers develop a neural diagnostic tool which can detect cardiac anomalies with 100% accuracy
Artificial intelligence (AI) has now taken another step forward in healthcare,...
Qclarity, produced by Paragon Biosciences, looks to improve the quality and speed of breast cancer diagnoses.
About 30 million women are screened for breast cancer...
FDA grants “Breakthrough Device” designation to Amprion's new technology as it is fast-tracked to market.
Parkinson's is a debilitating chronic, progressive neurodegenerative disease that is...
Longevity Vision fund announced today that they are investing in Freenome, a California-based firm that is developing "simple but very accurate blood tests ".
Longevity.Technology:...
Tracked.bio develops AI computer vision system that tracks flies and mice to reduce man-hours and increase data collected in Longevity studies.
A Danish start-up aims...
Bigger certainly doesn't mean better when it comes to Quicksilver's nutraceutical delivery methods.
The COVID-19 pandemic has caused an upturn in the supplements industry; from...
Following an R&D collaboration that began last year, Japanese pharma Astellas has announced it will acquire bioelectronics firm iota in $304m deal.
Last year's R&D...
Extending skinspan with non-invasive senetherapeutic proprietary peptide.
OneSkin is a Longevity company on a mission to transform the way we think about skin. Today the...
![Ozone therapy recently hit the headlines as one of the many treatment options being examined to mitigate the effects of COVID-19 [1], but it is also showing great promise in the treatment of neurodegenerative conditions such as Alzheimer’s and Parkinson's.](https://www.longevity.technology/wp-content/uploads/2020/10/Ozone-therapyW-218x150.jpg "Stopping neurodegeneration in its tracks with ozone therapy")
